Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat

Diabetes

Volumn 46, Issue 9, 1997, Pages 1393-1399

  Hallakou, Sophie ^a,b   Doaré, Liliane ^b   Foufelle, Fabienne ^a   Kergoat, Micheline ^b   Guerre Millo, Michèle ^a   Berthault, Marie France ^c   Dugail, Isabelle ^a   Morin, Joëlle ^a   Auwerx, Johan ^a   Ferré, Pascal ^a  

^a INSERM   (France)

^b LIPHA Research Laboratory   (France)

^c Lab d'Immunologie des Tumeurs   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; FATTY ACID SYNTHASE; ORAL ANTIDIABETIC AGENT; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP); PIOGLITAZONE;

ADIPOCYTE; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL DIFFERENTIATION; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE UTILIZATION; INSULIN RESISTANCE; LIPID METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 15444347751     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.46.9.1393     Document Type: Article

References (49)

1. Hofmann CA, Colca JR: New oral thiazolidinedione antidiabetic agents act as insulin sensitizers. Diabetes Care 15:1075-1078, 1992
2. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkinson WO, Wilson TM, Kliewer SA: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem 270:12953-12956, 1995
3. Willson TM, Cobb JE, Cowan DJ, Wiethe RW, Correa ID, Prakash SR, Beck KD, Moore LB, Kliewer SA, Lehmann JM: The structure-activity relationship between peroxisome proliferator-activated receptor γ agonist and the antihyperglycemic activity of thiazolidinediones. J Med Chem 39:665-668, 1996
4. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM: mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8:1224-1234, 1994
5. Hotamisligil GS, Spiegelman BM: Tumor necrosis factor α: a key component of the obesity-diabetes link. Diabetes 43:1271-1278, 1994
6. Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, Hotamisligil GS, Spiegelman BM: Altered gene expression for tumor necrosis factor-α and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134:264-270, 1994
7. Kletzien RF, Foellmi LA, Harris PKW, Wyse BM, Clarke SD: Adipocyte fatty acid-binding protein: regulation of gene expression in vivo and in vitro by an insulin-sensitizing agent. Mol Pharmacol 42:558-562, 1992
8. Harris PK, Kletzien RF: Localization of a pioglitazone response element in the adipocyte fatty acid-binding protein gene. Mol Pharmacol 45:439-445, 1994
9. Schoonjans K, Peinado-Onsurbe J, Heyman RA, Briggs M, Cayet D, Deeb S, Staels B, Auwerx J: PPARα and PPARγ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J 15:5336-5348, 1996
10. Tontonoz P, Hu E, Devine J, Beale EG, Spiegelman B: PPAR γ2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol 15:351-357, 1995
11. Tontonoz P, Graves RA, Budavari AI, Erdjument-Bromage H, Lui M, Hu E, Tempst P, Spiegelman BM: Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPARγ and RXRα. Nucleic Acids Res 22:5628-5634, 1994
12. Tontonoz P, Hu E, Spiegelman BM: Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79:1147-1156, 1994
13. Chawla A, Schwarz EJ, Dimaculangan DD, Lazar MA: Peroxisome proliferator-activated receptor (PPAR)γ: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 135:798-800, 1994
14. Kletzien RF, Clarke SD, Ulrich RG: Enhancement of adipocyte differentiation by an insulin-sensitizing agent. Mol Pharmacol 41:393-398, 1992
15. Sandouk T, Reda D, Hofmann C: Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells. Am J Physiol 264:C1600-C1608, 1993
16. Brun RP, Tontonoz P, Forman BM, Ellis R, Chen J, Evans RM, Spiegelman BM: Differential activation of adipogenesis by multiple PPAR isoforms. Genes Dev 10:974-984, 1996
17. Linn TC: Purification and crystallization of rat liver fatty acid synthase. Arch Biochem Biophys 209:613-619, 1981
18. Ferré P, Leturque A, Burnol A-F, Pénicaud L, Girard J: A method to quantify glucose utilization in vivo in skeletal muscle and white adipose issue of the anesthetized rat. Biochem J 228:103-110, 1985
19. Foufelle F, Gouhot B, Pégorier J-P, Perdereau D, Girard J, Ferré P: Glucose stimulation of lipogenic enzyme gene expression in culture white adipose tissue. J Biol Chem 267:20543-20546, 1992
20. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
21. Rodbell M: Metabolism of isolated fat cells: effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239:375-380, 1964
22. Rolland V, Dugail I, Le Liepvre X, Lavau M: Evidence of increased glyceraldehyde-3-phosphate dehydrogenase and fatty acid synthetase promoter activities in transiently transfected adipocytes from genetically obese rats. J Biol Chem 270:1102-1106, 1995
23. Sjöström L, Björntorp P, Vràna J: Microscopic fat cell size measurements on frozen-cut adipose tissue in comparison with automatic determinations of osmium-fixed fat cells. J Lipid Res 12:521-530, 1971
24. Cushman SW, Wardzala LJ: Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell: apparent translocation of intracellular transport systems to the plasma membrane. J Biol Chem 255:4758-4762, 1980
25. Reshef L, Hanson RW, Ballard FJ: A possible role for glyceroneogenesis in rat adipose tissue. J Biol Chem 245:5979-5984, 1970
26. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman M: Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432, 1994
27. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269:540-543, 1995
28. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543-546, 1995
29. De Vos P, Lefebvre A-M, Miller SG, Guerre-Millo M, Wong K, Saladin R, Hamann L, Staels B, Briggs M, Auwerx J: Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor γ. J Clin Invest 98:1004-1009, 1996
30. Zhang B, Graziano MP, Smith RG: Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice. J Biol Chem 271:9455-9459, 1996
31. Cao Z, Umek RM, McKnight SL: Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 5:1538-1552, 1991
32. Dani C, Doglio A, Amri E-Z, Bardon S, Fort P, Bertrand B, Grimaldi P, Ailhaud G: Cloning and regulation of a mRNA specifically expressed in the preadipose state. J Biol Chem 264:10119-10125, 1989
33. Ibrahimi A, Bertrand B, Bardon S, Amri E-Z, Grimaldi P, Ailhaud G, Dani C: Cloning of α2 chain of type VI collagen and expression during mouse development. Biochem J 289:141-147, 1993
34. Ikeda H, Taketomi S, Sugiyama Y, Shimura Y, Sohda T, Meguro K, Fujita T: Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals. Arzneimittelforschung 40:156-162, 1990
35. Hofmann C, Lorenz K, Colca JR: Glucose transport deficiency in diabetic animals is corrected by treatment with the oral antihyperglycemic agent pioglitazone. Endocrinology 129:1915-1925, 1991
36. Kobayashi M, Iwanishi M, Egawa K, Shigeta Y: Pioglitazone increases insulin sensitivity by activating insulin receptor kinase. Diabetes 41:476-483, 1992
37. Sugiyama Y, Shimura Y, Ikeda H: Effects of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats. Arzneimittelforschung 40:436-439, 1990
38. Hofmann CA, Edwards CW III, Hillman RM, Colca JR: Treatment of insulin-resistant mice with the oral antidiabetic agent pioglitazone: evaluation of liver GLUT2 and phosphoenolpyruvate carboxykinase expression. Endocrinology 130:735-740, 1992
39. De Souza CJ, Yu JH, Robinson DD, Ulrich RG, Meglasson MD: Insulin secretory defect in Zucker fa/fa rats is improved by ameliorating insulin resistance. Diabetes 44:984-991, 1995
40. Wu Z, Xie Y, Bucher NLR, Farmer SR: Conditional ectopic expression of C/EBPβ in NIH-3T3 cells induces PPARγ and stimulates adipogenesis. Genes Dev 9:2350-2363, 1995
41. Kaester KH, Christy RJ, Lane MD: Mouse insulin-responsive glucose transporter gene: characterization of the gene and transactivation by the CCAAT-enhancer binding protein. Proc Natl Acad Sci USA 87:251-255, 1990
42. McKeon C, Pham T: Transactivation of the human insulin receptor gene by CCAAT/enhancer binding protein. Biochem Biophys Res Commun 174:721-728, 1991
43. Miller SG, De Vos P, Guerre-Millo M, Wong K, Hermann T, Staels B, Briggs MR, Auwerx J: The adipocyte specific transcription factor C/EBP α modulates human ob gene expression. Proc Natl Acad Sci USA 93:5507-5511, 1996
44. Hwang C-S, Mandrup S, MacDougald OA, Geiman D, Lane MD: Transcriptional activation of the mouse obese (ob) gene by CCAAT/enhancer binding protein α. Proc Natl Acad Sci USA 93:873-877, 1996
45. Saladin R, De Vos P, Guerre-Millo M, Leturque A, Girard J, Staels B, Auwerx J: Transient increase in obese gene expression after food intake or insulin administration. Nature 377:527-529, 1995
46. Slieker LJ, Sloop KW, Surface PL, Kriauciunas A, LaQuier F, Manetta J, Bue-Valleskey J, Stephens TW: Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J Biol Chem 271:5301-5304, 1996
47. Murakami T, Lida M, Shima K: Dexamethasone regulates obese expression in isolated rat adipocytes. Biochem Biophys Res Commun 214:1260-1267, 1995
48. Iwamoto Y, Kuzuya T, Matsuda A, Awata T, Kumakura S, Inooka G, Shiraishi I: Effects of new oral antidiabetic agent CS-O45 on glucose tolerance and insulin secretion in patients with NIDDM. Diabetes Care 14:1083-1086, 1991
49. Iwamoto Y, Kosaka K, Kuzuya T, Akanuma Y, Shigeta Y, Kaneko T: A new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy. Diabetes Care 19:151-156, 1996